| 2018-05-31 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0301% | $100.31 | $3.01M | -13.32% | |
| 2014-05-21 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 70,000 0.0934% | $53.80 | $3.77M | +73.79% | |
| 2013-06-12 | Verastem, Inc. VSTM | director | 46,342 0.2163% | $9.60 | $444,851 | +24.24% | ||
| 2013-06-11 | Verastem, Inc. VSTM | director | 50,000 0.2341% | $9.22 | $460,955 | +29.74% | ||
| 2013-05-13 | Verastem, Inc. VSTM | director | 50,000 0.2413% | $9.73 | $486,750 | +26.67% | ||
| 2013-05-01 | Verastem, Inc. VSTM | director | 20,000 0.0983% | $9.66 | $193,244 | +30.01% | ||
| 2013-04-17 | Verastem, Inc. VSTM | director | 11,262 0.0542% | $9.50 | $106,978 | +29.41% | ||
| 2012-12-18 | Verastem, Inc. VSTM | director | 12,386 0.0553% | $7.87 | $97,478 | +20.56% | ||
| 2012-02-01 | Verastem, Inc. VSTM | director | 500,000 3.0936% | $10.00 | $5M | -10.82% | ||
| 2004-05-27 | Alnylam Pharmaceuticals, Inc. ALNY | director | 232,500 – | $0 | $0 |